Increasing Incidence OF Influenza In The Antivirals Market: Pivotal Factor Influencing Antivirals Market Growth in 2025

"Increasing Incidence OF Influenza In The Antivirals Market: Pivotal Factor Influencing Antivirals Market Growth in 2025Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antivirals Market Size Growth Forecast: What to Expect by 2025?
The size of the antivirals market has seen significant expansion in the past few years. The market is forecasted to increase from $106.13 billion in 2024 to $114.7 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the historic period include the prevalence of viral diseases, public health issues, expiration of patents, and various government undertakings.

How Will the Antivirals Market Size Evolve and Grow by 2029?
The antivirals market is forecasted to experience robust expansion in the coming years. The market size is predicted to increase to $153.67 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The rise projected for the forecast duration can be linked to the appearance of new viral threats and international health schemes. Dominant trends expected within this forecast period incorporate advancements in technology, telemedicine, digital health, and personalized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

What Drivers Are Propelling the Growth of Antivirals Market Forward?
The antiviral market is projected to expand due to a rising number of influenza cases. Influenza, otherwise known as the flu, is a highly infectious viral infection of the respiratory system, caused by influenza viruses that target the nose, throat, and lungs. Antivirals are key in treating influenza as they inhibit the replication and dissemination of influenza viruses within the human body. For example, the Centers for Disease Control and Prevention, a health agency based in the U.S, stated in October 2022 that during the 2021-2022 season, there were 9 million flu cases, 4 million medical visits related to the flu, 100,000 hospitalizations due to the flu, and 5,000 flu fatalities. Consequently, the heightened occurrence of influenza is fueling the antiviral market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Which Emerging Trends Are Transforming the Antivirals Market in 2025?
Leading businesses in the antiviral market are concentrating their efforts on creating innovative therapies like oral antiviral treatment, in the pursuit of increasing patient adherence, broadening accessibility, lowering healthcare expenses, and offering more effective and handy alternatives for viral infection management. Oral antiviral treatments denote medicines that are consumed orally to fight off viral infections. These treatments operate by curbing the replication or spread of viruses within the organism, lessening the intensity and span of the infection. For example, Pfizer, a pharmaceutical company based in the US, received approval for Paxlovid in May 2023, establishing it as the Food and Drug Administration's first-ever oral antiviral treatment for adult COVID-19 patients, the FDA being a government agency in the U.S. This authorization is significantly important as it introduces a fresh therapeutic choice for handling COVID-19, particularly when the pandemic is shifting towards an endemic stage. Paxlovid is primarily targeted towards adults suffering from mild-to-moderate COVID-19 who face a high risk of developing a severe disease, potentially leading to hospitalization or death.

What Are the Key Segments in the Antivirals Market?
The antivirals market covered in this report is segmented -

1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Who Are the Key Players Shaping the Antivirals Market's Competitive Landscape?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

What Geographic Markets Are Powering Growth in the Antivirals Market?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.